NEWS

STING fever is sweeping through the cancer immunotherapy world – Chemical & Engineering News

Chemical & Engineering NewsSTING fever is sweeping through the cancer immunotherapy worldChemical & Engineering NewsThe crystal structure of human STING, with the agonist ADU-S100, currently in a Phase I clinical trial from Aduro Biotech and Novartis. … Continue reading

Enabling technology for emerging gene therapies – Medical Xpress

Medical XpressEnabling technology for emerging gene therapiesMedical XpressDNA insertion, or transfection, which is of most interest in gene therapy, is significantly more challenging. Yet the combined application of mechanical and electrical forces pi… Continue reading

Expert Highlights Immunotherapy Use in Stage III NSCLC – OncLive

CAR T-cell therapy shows efficacy for extramedullary ALL – Healio

CAR T-cell therapy shows efficacy for extramedullary ALLHealioSALT LAKE CITY — Activity of anti-CD22 chimeric antigen receptor T-cell therapy occurred among children and young adults with extramedullary acute lymphoblastic leukemia, despite delayed tim… Continue reading

CAR T-cell therapy shows efficacy for extramedullary ALL – Healio

CAR T-cell therapy shows efficacy for extramedullary ALLHealioSALT LAKE CITY — Activity of anti-CD22 chimeric antigen receptor T-cell therapy occurred among children and young adults with extramedullary acute lymphoblastic leukemia, despite delayed tim… Continue reading

First Longeveron Mesenchymal Stem Cell Treatment Administered to an Infant with Rare Heart Condition as Part of … – PR Newswire (press release)

Enabling technology for emerging gene therapies – EurekAlert (press release)

EurekAlert (press release)Enabling technology for emerging gene therapiesEurekAlert (press release)DNA insertion, or transfection, which is of most interest in gene therapy, is significantly more challenging. Yet the combined application of mechanical … Continue reading